ENSYSCE BIOSCIENCES INC (ENSC) Stock Income Statement
NASDAQ:ENSC - Nasdaq - US2936025046 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.22M | 5.21M | 2.23M | 2.52M | 3.53M | |||
| Minority Interest Expense | N/A | 100.00 | 13.20K | 40.00K | 60.00K | |||
| Operating Expenses | 13.08M | 11.94M | 12.95M | 26.75M | 23.40M | |||
| Research and Development | 8.33M | 7.22M | 7.59M | 19.84M | 4.69M | |||
| Selling, General, and Administrative Expenses | 4.75M | 4.72M | 5.36M | 6.91M | 18.71M | |||
| Operating Income | -6.85M | -6.73M | -10.72M | -24.23M | -19.87M | |||
| Interest Income/Expense | -46.30K | -1.29M | -354.00K | -110.00K | -620.00K | |||
| Other Income/Expense | 84.90K | 33.60K | 445.90K | 4.09M | -8.65M | |||
| Non Recurring Items | N/A | N/A | 0.00 | -3.96M | N/A | |||
| Income Before Taxes | -6.82M | -7.99M | -10.63M | -24.21M | -29.15M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -6.82M | -7.99M | -10.63M | -25.09M | -29.89M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.62 | -11.45 | -70.40 | -2.09K | -5.34K | |||
| Non GAAP EPS | -6.54 | -13.40 | -79.50 | -1.49K | N/A | |||
| Statistics | ||||||||
| Profit Margin | -109.51% | -153.31% | -476.40% | -995.63% | -846.74% | |||
| Operating Profit Margin | -110.13% | -129.18% | -480.53% | -961.51% | -562.89% | |||
All data in USD